Abiopharma

🔍 Rasmussen Trangsrud Teresa J (Director)

Company: FULLER H B CO (FUL)

Report Date: 2025-08-29

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-29 | Code: H | shares_owned_after: 2,343.00
• Acquired 968 shares of Stock Units (Derivative)
  Date: 2025-08-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 18,556.15 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F3

Footnotes:

• F1: These units convert into shares of common stock on a 1-for-1 basis.
• F2: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law.
• F3: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors' Deferred Compensation Plan.